Date published: 2026-7-21

1-800-457-3801

SCBT Portrait Logo
Seach Input

β6 Tubulin CRISPR/Cas9 KO Plasmid (h): sc-400062

0.0(0)
Write a reviewAsk a question

Datasheets
  • Target species: human
  • 20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
  • β6 Tubulin CRISPR/Cas9 Knockout (KO) Plasmid (h) is a pool of plasmids, each encoding Cas9 nuclease and a target-specific 20 nt guide RNA (gRNA) designed for maximum knockout efficiency using sequences derived from the GeCKO v2 library
  • gRNA sequences direct Cas9 to induce site-specific double-strand breaks (DSBs) in the β6 Tubulin genomic locus, resulting in gene knockout through non-homologous end joining (NHEJ)
  • The puromycin resistance and RFP genes are flanked by LoxP sites, enabling removal of selection markers via Cre recombinase (Cre Vector: sc-418923) after establishing stable knockout cell lines
    Gene Editing Promo Banner

    Ordering Information

    Product NameCatalog #UNITPriceQtyFAVORITES

    β6 Tubulin CRISPR/Cas9 KO Plasmid (h)

    sc-400062
    20 µg
    $397.00

    Overview

    TUBB6 encodes human β6 tubulin, a β-tubulin isotype that heterodimerizes with α-tubulin to form microtubules, supporting cytoskeletal architecture and intracellular transport. Microtubule dynamics governed by tubulin isotype composition regulate mitotic spindle assembly, chromosome segregation, and cell-cycle progression, and also shape cell polarity and motility. β6 tubulin participates in pathways controlling vesicle trafficking and organelle positioning through interactions with microtubule-associated proteins and motor complexes. Dysregulation of tubulin networks and microtubule behavior is linked to proliferative phenotypes, chromosomal instability, and altered migration programs relevant to cancer biology and other cytoskeleton-associated disorders.

    β6 Tubulin CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the TUBB6 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the TUBB6 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.

    The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the TUBB6 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish β6 Tubulin protein expression.

    This CRISPR knockout system enables efficient generation of TUBB6-deficient cell models for investigation of β6 Tubulin signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.

    Key Features

    • sgRNAs targeting TUBB6 exon(s) critical for β6 Tubulin function
    • Co-expression of SpCas9 and sgRNA from a single plasmid for simplified delivery
    • GFP reporter for identification of transfected cells
    • Pool of plasmids targeting multiple TUBB6 genomic sites to improve knockout efficiency
    • Compatible with delivery by transfection

    Design Variants

    CRISPRs +/- HDRs

    • gRNAs encoded by β6 Tubulin CRISPR/Cas9 KO Plasmid (h) and β6 Tubulin CRISPR/Cas9 KO Plasmid (h2) target distinct sites within the TUBB6 locus. One or both targeting designs may be available. See Related Products for availability.
    • HDR donor constructs encoded by β6 Tubulin HDR Plasmid (h) and β6 Tubulin HDR Plasmid (h2) contain a puromycin resistance cassette and an RFP reporter flanked by TUBB6 homology arms to support homology-directed repair at defined TUBB6 target sites corresponding to the CRISPR/Cas9 KO designs. HDR donor availability may vary. See Related Products for availability.

    For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.